Nephros Inc.
41 Grand Avenue
River Edge,
NJ 07661
United States - Map
Phone: 201-343-5202
Fax: 201-343-5207
Web Site: http://www.nephros.com
| Nephros, Inc. primarily engages in the development of hemodiafiltration (HDF) products and technologies for treating patients with end stage renal disease. The company also offers OLpur HD 190 high-flux dialyzer cartridge for use with hemodialysis or HDF machines, as well as OLpur MD190 and OLpur MD220 dialyzers in Europe. It has three products in various stages of development in HDF modality, such as OLpur MDHDF filter series for HDF therapy; OLpur H2H, an add-on module designed to allow the common types of hemodialysis machines to be used for HDF therapy; and OLpur NS2000 system, a stand-alone HDF machine and associated filter technology. The company also develops dual stage ultrafilter water filtration system. It markets its products primarily to healthcare providers, such as hospitals, dialysis clinics, managed care organizations, and nephrology physician groups. Nephros was founded in 1997 and is headquartered in River Edge, New Jersey. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Ernest A. Elgin III, 43
Chief Exec. Officer, Pres |
$
105.00K | N/A | Mr. Gerald J. Kochanski , 55
Chief Financial Officer, Principal Accounting Officer, Sec. and Treasurer |
$
156.00K | N/A | Ms. Joleen C. Turner ,
VP of Marketing and VP of Bus. Devel. |
N/A
| N/A | Dr. Gregory Collins Ph.D., 49
Sr. Scientist |
N/A
| N/A | Mr. Nicholas Staub B.A, 52
Director of Sales |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.48% Nasdaq 
Profile
